Blog

Douglas Flora is a speaker at Total Health’s 10th Annual West Oncology Conference

Douglas Flora/LinkedIn

Dec 5, 2024, 15:11

Douglas Flora is a speaker at Total Health’s 10th Annual West Oncology Conference

Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, posted on LinkedIn:

“Thrilled to announce that I’ll be speaking on AI in Oncology at Total Health’s 10th Annual West Oncology Conference!

West Oncology Conference will serve as a valuable forum for presenting and discussing new research findings in oncology education. Learners will be provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting will be an in-person conference with on-demand access for registered attendees.

Why Attend?

Earn 7.50 CE/CME credits & MOC Points—completely free!
Explore the latest research and treatment approaches.
Network with peers and thought leaders in a relaxed, professional setting.

When: Saturday and Sunday, February 8-9, 2025
Where: Hilton Memphis
939 Ridge Lake Boulevard, Memphis, TN

Join us for a weekend of impactful learning and collaboration. I can’t wait to connect with you in Memphis, TN!

Learn More and Register for free today: Total Health | Oncology – 2025 West Oncology Conference.”

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.